Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

65
Milken Institute Launches “Early Warning” Initiative for Emerging Pandemic Threats as COVID-19 Cases Increase article
Milken Institute Launches “Early Warning” Initiative for Emerging Pandemic Threats as COVID-19 Cases Increase
Washington, D.C. – Dec.
Dec 1, 2020
One Out of 10 People Are Affected by Rare Diseases Globally—and We Must Listen to Their Stories article
One Out of 10 People Are Affected by Rare Diseases Globally—and We Must Listen to Their Stories
We are in a period of profound unrest that is testing the strength of our global community. Our worl
d has been turned upside down by the COVID-19 pandemic., When we develop and deliver medicines and innovation, we must think about the uniqueness of the individual, not just their disease., In science, the way one patient’s story begins can have a profound impact on the way many more stories will unfold.
Nov 25, 2020
Milken Institute COVID-19 Response article
Milken Institute COVID-19 Response
Statement from Milken Institute Chairman Michael Milken All of us at Milken Institute are working c
losely with leaders in industry, government, and medical research organizations to: mitigate the spread of COVID-19;
Mar 15, 2020
Changing the Story of Cancer: From Loss to Hope article
Changing the Story of Cancer: From Loss to Hope
Cancer is personal. Almost half of all men and a third of all women in the United States will receiv
e a cancer diagnosis at some point in their lives. Yet this diagnosis still comes as a shock and sparks the fear of loss.
Oct 16, 2019
Who Gains More From Medical Innovation: Patients Or Drug Manufacturers? article
Who Gains More From Medical Innovation: Patients Or Drug Manufacturers?
The social value of any production activity (e.g., a new drug) is the value consumers place on the p
roduct beyond the cost or resources involved in the product’s manufacturing.
Jun 6, 2019
Boston, New York, Philadelphia, Chicago and Los Angeles Are Nation's Leading Centers for Health Care Industries article
Boston, New York, Philadelphia, Chicago and Los Angeles Are Nation's Leading Centers for Health Care Industries
LOS ANGELES — Cities and regions with the greatest health-care resources could be big economic winne
rs in the decades ahead.
Apr 1, 2014
New drugs are worth the price; they extend lives and reduce other health-care costs, says economist in latest Milken Institute Review article
New drugs are worth the price; they extend lives and reduce other health-care costs, says economist in latest Milken Institute Review
LOS ANGELES — Are modern drugs worth the price? Economist Frank R. Lichtenberg answers his own ques
tion with a resounding "yes" in a detailed analysis of "The Value of New Drugs" in the latest issue of The Milken Institute Review.
Apr 1, 2014
Pharmaceutical industry in Illinois contributes $9 billion a year to state economy, but the state's position is slipping, Milken Institute study finds article
Pharmaceutical industry in Illinois contributes $9 billion a year to state economy, but the state's position is slipping, Milken Institute study finds
LOS ANGELES — The pharmaceutical industry in Illinois is one of its most valuable economic resources
, accounting directly and indirectly for $9 billion a year in Gross State Product (GSP) and more than 100,000 jobs, but the state′s position in the pharm
Apr 1, 2014
Boston, San Francisco Bay Area and Greater Philadelphia Are Top Life Sciences Clusters in the U.S., New Milken Institute Study Shows article
Boston, San Francisco Bay Area and Greater Philadelphia Are Top Life Sciences Clusters in the U.S., New Milken Institute Study Shows
If the life sciences industry is the holy grail of economic development, as many public policy offic
ials believe, then Boston, Greater San Francisco, Greater Philadelphia and Greater New York are in the best position to gain from this dynamic industry i
Apr 1, 2014
Electronic Medical Records: A Bridge to Faster Cures article
Electronic Medical Records: A Bridge to Faster Cures
Washington, D.C.
Apr 1, 2014
Financial innovations can help produce new medicines through funding of early-stage drug development, Milken Institute report says article
Financial innovations can help produce new medicines through funding of early-stage drug development, Milken Institute report says
Despite the enormous potential of biomedical research to cure disease, public and private funding ha
s declined — a trend that could jeopardize efforts to find improved treatments for people with life-threatening illnesses.
Apr 1, 2014
From Passengers to Co-Pilots: Patient Roles Expand article
From Passengers to Co-Pilots: Patient Roles Expand
WASHINGTON – The elevated role of medical research on the U.S.
Jun 10, 2015